Literature DB >> 6173119

Membrane transport considerations in high-dose methotrexate regimens with leucovorin rescue.

I D Goldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6173119

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

1.  Trimetrexate: a new antifol entering clinical trials.

Authors:  P J O'Dwyer; D D Shoemaker; J Plowman; J Cradock; A Grillo-Lopez; B Leyland-Jones
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

2.  The inability of oral leucovorin to elevate CSF 5-methyl-tetrahydrofolate following high dose intravenous methotrexate therapy.

Authors:  J Allen; G Rosen; H Juergens; B Mehta
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

3.  New folate analogs of the 10-deaza-aminopterin series. Basis for structural design and biochemical and pharmacologic properties.

Authors:  F M Sirotnak; J I DeGraw; D M Moccio; L L Samuels; L J Goutas
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behavior.

Authors:  N Lena; A M Imbert; T Pignon; R Favre; G Meyer; J P Cano; Y Carcassonne
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.